Literature DB >> 18322288

Pharmacogenomics--ready for prime time?

Susan B Shurin, Elizabeth G Nabel.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18322288     DOI： 10.1056/NEJMe0800801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  [Pharmacogenetics].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

2.  Debating clinical utility.

Authors:  Wylie Burke; A-M Laberge; N Press
Journal:  Public Health Genomics       Date:  2010-04-15       Impact factor: 2.000

3.  Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.

Authors:  Chun Li; Ute I Schwarz; Marylyn D Ritchie; Dan M Roden; C Michael Stein; Daniel Kurnik
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

4.  Pharmacogenomics, evidence, and the role of payers.

Authors:  P A Deverka
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

Review 5.  Arrhythmia pharmacogenomics: methodological considerations.

Authors:  Dan M Roden; Prince J Kannankeri; Dawood Darbar
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Warfarin pharmacogenomics.

Authors:  Jiayi Li; Shan Wang; Joseph Barone; Brian Malone
Journal:  P T       Date:  2009-08

Review 7.  Optimal loading dose for the initiation of warfarin: a systematic review.

Authors:  Carl Heneghan; Sally Tyndel; Clare Bankhead; Yi Wan; David Keeling; Rafael Perera; Alison Ward
Journal:  BMC Cardiovasc Disord       Date:  2010-04-19       Impact factor: 2.298

Review 8.  Maternal-fetal and neonatal pharmacogenomics: a review of current literature.

Authors:  Y J Blumenfeld; M F Reynolds-May; R B Altman; Y Y El-Sayed
Journal:  J Perinatol       Date:  2009-11-19       Impact factor: 2.521

Review 9.  Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.

Authors:  Michael V Holmes; Tina Shah; Christine Vickery; Liam Smeeth; Aroon D Hingorani; Juan P Casas
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

10.  The cycle of genome-directed medicine.

Authors:  Janet A Buchanan; Andrew R Carson; David Chitayat; David Malkin; M Stephen Meyn; Peter N Ray; Cheryl Shuman; Rosanna Weksberg; Stephen W Scherer
Journal:  Genome Med       Date:  2009-02-02       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.